42 biotech investors in London
We list 42 biotech investors in London as of November 2026: each was checked on its own website or an official register, and the list was last checked on 5 Nov 2026.
Top 5 biotech investors in London, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the UK (15: full marks when the firm names the UK as where it invests, half when it says Europe or global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
Sofinnova Partners
Type: VC firm · HQ: France (London office) · Stages: Seed, Series A, Series B, Growth · Focus: Biotech, Healthtech, Fintech, Agritech · Latest activity: New fund, Nov 2025 · Fund size or assets: €4.0B (own site)
Latest fund filing dated Nov 2025; €4.0B on file (own site); 88% of its observed portfolio is biotech and life sciences; names the UK as where it invests; 8 named decision-makers on file.
Highland Europe
Type: VC firm · HQ: London, United Kingdom · Stages: Growth · Focus: Biotech, AI, Cybersecurity, SaaS · Latest activity: New fund, Jul 2026 · Fund size or assets: €1.1B (own site)
Latest fund filing dated Jul 2026; €1.1B on file (own site); 29% of its observed portfolio is biotech and life sciences; names the UK as where it invests; 8 named decision-makers on file.
Claret Capital Partners
Type: Venture debt · HQ: London, United Kingdom · Stages: Series B, Growth, Late stage · Focus: Biotech, Healthtech, Climate Tech, SaaS · Latest activity: New deal, Oct 2026 · Fund size or assets: €575M (own site)
Dated new deal in Oct 2026; €575M on file (own site); states biotech and life sciences as a focus; 8 named decision-makers on file.
Empirical Ventures
Type: SEIS/EIS fund · HQ: London, United Kingdom · Stages: Pre-seed, Seed · Focus: Biotech, Energy, Semiconductor, Deep Tech · Latest activity: New deal, Jul 2026 · Fund size or assets: £50M (own site)
Dated new deal in Jul 2026; £50M on file (own site); states biotech and life sciences as a focus; names the UK as where it invests; 6 named decision-makers on file.
UKI2S
Type: VC firm · HQ: London, United Kingdom · Stages: Pre-seed, Seed · Focus: Biotech, Healthtech, AI, Deep Tech · Latest activity: New deal, Jul 2025 · Fund size or assets: £150M (own site)
Dated new deal in Jul 2025; £150M on file (own site); 46% of its observed portfolio is biotech and life sciences; names the UK as where it invests; 8 named decision-makers on file.
First 21 of 42 biotech investors in London
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| Sofinnova Partners | VC firm | France (London office) | Seed, Series A, Series B, Growth | Biotech, Healthtech, Fintech, Agritech | New fund, Nov 2025 | €4.0B (own site) | 5 Nov 2026 | 8 names · Unlock |
| Highland Europe | VC firm | London, United Kingdom | Growth | Biotech, AI, Cybersecurity, SaaS | New fund, Jul 2026 | €1.1B (own site) | 4 Nov 2026 | 8 names · Unlock |
| Claret Capital Partners | Venture debt | London, United Kingdom | Series B, Growth, Late stage | Biotech, Healthtech, Climate Tech, SaaS | New deal, Oct 2026 | €575M (own site) | 4 Nov 2026 | 8 names · Unlock |
| Empirical Ventures | SEIS/EIS fund | London, United Kingdom | Pre-seed, Seed | Biotech, Energy, Semiconductor, Deep Tech | New deal, Jul 2026 | £50M (own site) | 4 Nov 2026 | 6 names, firm email · Unlock |
| UKI2S | VC firm | London, United Kingdom | Pre-seed, Seed | Biotech, Healthtech, AI, Deep Tech | New deal, Jul 2025 | £150M (own site) | 4 Nov 2026 | 8 names · Unlock |
| Advent Life Sciences | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Biotech, Healthtech | New fund, May 2026 | 4 Nov 2026 | 8 names, firm email · Unlock | |
| Vsquared Ventures | VC firm | Germany (London office) | Pre-seed, Seed, Series A | Biotech, AI, Industrial Tech, Deep Tech | Portfolio news, Nov 2026 | 5 Nov 2026 | 7 names · Unlock | |
| Elbow Beach | VC firm | London, United Kingdom | Pre-seed, Seed | Biotech, Energy, Climate Tech, Agritech | New deal, Oct 2026 | 4 Nov 2026 | 8 names, firm email · Unlock | |
| Calculus Capital | SEIS/EIS fund | London, United Kingdom | Growth | Biotech, Fintech, SaaS, Healthtech | Portfolio news, Jun 2026 | 4 Nov 2026 | 8 names, firm email · Unlock | |
| EMV Capital | VC firm | London, United Kingdom | Seed, Series A | Biotech, Healthtech, Fintech, Deep Tech | New deal, Jul 2026 | 4 Nov 2026 | 8 names, firm email · Unlock | |
| SV Health Investors | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Biotech, Healthtech, Medtech | New fund, May 2025 | $4.0B (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Zinc | Accelerator | London, United Kingdom | Pre-seed | Biotech, Healthtech, AI, Climate Tech | Portfolio news, Jul 2026 | 4 Nov 2026 | 8 names, firm email · Unlock | |
| Medicxi | VC firm | London, United Kingdom | Pre-seed, Seed, Series A, Series B, Late stage | Biotech, Healthtech | New fund, Nov 2025 | €500M (own site) | 5 Nov 2026 | 8 names, firm email · Unlock |
| Future Planet Capital | VC firm | London, United Kingdom | Seed, Series A, Growth | Biotech, Healthtech, AI, Mobility | Portfolio news, Apr 2025 | $570M (own site) | 4 Nov 2026 | 5 names, firm email · Unlock |
| Ventures Together | Angel network | London, United Kingdom | Seed | Biotech, AI, Fintech, Cybersecurity | Portfolio news, Oct 2026 | 4 Nov 2026 | firm email · Unlock | |
| IQ Capital | VC firm | London, United Kingdom | Pre-seed, Seed, Series A | Biotech, AI, Energy, Healthtech | Portfolio news, Aug 2026 | 4 Nov 2026 | 5 names, firm email · Unlock | |
| Octopus Ventures | VC firm | London, United Kingdom | Pre-seed, Seed, Series A, Series B | Biotech, Fintech, Healthtech, Climate Tech | New deal, Feb 2026 | 4 Nov 2026 | 8 names · Unlock | |
| Eight Roads | VC firm | London, United Kingdom | Series B, Growth | Biotech, Healthtech, SaaS, Fintech | $450M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock | |
| Twin Path Ventures | VC firm | London, United Kingdom | Pre-seed, Seed | Biotech, AI, Healthtech, Fintech | Portfolio news, Dec 2025 | 4 Nov 2026 | 3 names · Unlock | |
| LifeArc Ventures | Corporate VC | London, United Kingdom | Seed, Series A | Biotech, Healthtech, Medtech | £1.3B (own site) | 5 Nov 2026 | 8 names · Unlock | |
| Syncona | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Biotech, Healthtech | Portfolio news, Mar 2026 | 5 Nov 2026 | 8 names, firm email · Unlock |
You are seeing 21 of 42. The full list adds 21 more investors and 244 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
How these 42 break down
By stage
| Stage | On this list | Share |
|---|---|---|
| Pre-Seed | 19 | 45% |
| Seed | 31 | 74% |
| Series A | 20 | 48% |
| Series B | 12 | 29% |
| Growth | 16 | 38% |
Stage is our research. A firm can back more than one stage.
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 29 | 69% |
| Venture debt | 2 | 5% |
| SEIS/EIS fund | 2 | 5% |
| Angel network | 2 | 5% |
| Fund manager | 2 | 5% |
| Single family office | 2 | 5% |
Method and limits
- Source
- No row on this list rests on an SEC filing. All 42 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio. Place: an office in London.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the UK (15: full marks when the firm names the UK as where it invests, half when it says Europe or global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 5 Nov 2026.
- Fill rates
- Of 42 rows: stage 41, sector 42, fund size 13, website 42. In the paid file: named decision-makers on 38 rows, firm email on 26, LinkedIn page on 35, check size on 19.
- Corrections
- Email [email protected] or use the update form. We act within 5 working days.
Questions
How many biotech investors in London are there?
We list 42 as of November 2026. 18 of the 42 have a fund filing or a dated deal in the last 12 months.
Which biotech investors in London raised a new fund in the last 12 months?
2 of the 42 have a fund filing dated in the last 12 months: Highland Europe (Jul 2026) and Medicxi (Nov 2025). 18 of the 42 have a fund filing or a dated deal in that time.
How do I contact biotech investors in London?
The paid file holds 244 named decision-makers across 38 of these 42 and a firm email for 26. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.
Where does the data on biotech investors in London come from?
All 42 rows were checked on the firm's own website, with official registers and national venture capital association directories as the starting point. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 5 Nov 2026 at the latest. The whole file is re-verified twice a year.
Related lists
AI investors in London (142)SaaS investors in London (141)Fintech investors in London (113)Healthtech investors in London (113)Climate tech investors in London (71)Consumer investors in London (67)Deep tech investors in London (66)B2B investors in London (49)Medtech investors in London (36)Energy investors in London (36)Media investors in London (34)Cybersecurity investors in London (28)Future of work investors in London (24)Industrial tech investors in London (22)Hardware investors in London (20)Mobility investors in London (19)Edtech investors in London (18)Developer tools investors in London (16)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to biotech and life sciences and the UK. Guide: how to build an investor list. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.